<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The E23K variant in the Kir6.2 subunit of the ATP-sensitive <z:chebi fb="0" ids="29103">K(+)</z:chebi> channel (K(ATP) channel) is associated with increased risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>The present study was undertaken to increase our understanding of the mechanisms responsible </plain></SENT>
<SENT sid="2" pm="."><plain>To avoid confounding effects of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>, insulin secretion and action were studied in subjects with the variant who had <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance </plain></SENT>
<SENT sid="3" pm="."><plain>RESEARCH DESIGN AND METHODS: Nine subjects with the E23K genotype K/K and nine matched subjects with the E/E genotype underwent 5-h oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance tests (OGTTs), graded <z:chebi fb="105" ids="17234">glucose</z:chebi> infusion, and hyperinsulinemic-euglycemic clamp with stable-isotope-labeled tracer infusions to assess insulin secretion, action, and clearance </plain></SENT>
<SENT sid="4" pm="."><plain>A total of 461 volunteers consecutively genotyped for the E23K variant also underwent OGTTs </plain></SENT>
<SENT sid="5" pm="."><plain>Functional studies of the <z:mp ids='MP_0002169'>wild-type</z:mp> and E23K variant <z:chebi fb="120" ids="26216">potassium</z:chebi> channels were conducted </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Insulin secretory responses to oral and intravenous <z:chebi fb="105" ids="17234">glucose</z:chebi> were reduced by approximately 40% in <z:chebi fb="105" ids="17234">glucose</z:chebi>-tolerant subjects homozygous for E23K </plain></SENT>
<SENT sid="7" pm="."><plain><z:mpath ids='MPATH_458'>Normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance with <z:mp ids='MP_0003059'>reduced insulin secretion</z:mp> suggests a change in insulin sensitivity </plain></SENT>
<SENT sid="8" pm="."><plain>The hyperinsulinemic-euglycemic clamp revealed that hepatic insulin sensitivity is approximately 40% greater in subjects with the E23K variant, and these subjects demonstrate <z:mp ids='MP_0002891'>increased insulin sensitivity</z:mp> after oral <z:chebi fb="105" ids="17234">glucose</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>The reconstituted E23K channels confirm reduced sensitivity to inhibitory ATP and increase in open probability, a direct molecular explanation for <z:mp ids='MP_0003059'>reduced insulin secretion</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: The E23K variant leads to overactivity of the K(ATP) channel, resulting in <z:mp ids='MP_0003059'>reduced insulin secretion</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>Initially, insulin sensitivity is enhanced, thereby maintaining <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance </plain></SENT>
<SENT sid="12" pm="."><plain>Presumably, over time, as insulin secretion <z:hpo ids='HP_0002527'>falls</z:hpo> further or <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> develops, <z:chebi fb="105" ids="17234">glucose</z:chebi> levels rise resulting in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>